To know the Efficacy of Gokshuradi Guggulu and Bhunimbadi Yoga in the Management of Chronic Kidney Disease

An Open Labelled Single Arm Prospective Clinical Study To Evaluate The Combined Efficacy Of Gokshuradi Guggulu and Bhunimbadi Yoga in the Management Of Chronic Kidney Disease Vis A Vis Jirna Vrukka Roga - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087956

Enrollment

Registered

2025-05-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. All subjects who have given consent and signed consent letter will only be included. 2. All subjects diagnosed as CKD stage 1 or 2 or 3a or 3b. 3. eGFR greater than 30 ml by min by 1.73m2 till 90 ml by min by 1.73m2 will also be included. 4. Newly diagnosed and CKD follow up subjects with standard renal supportive care will also be included. 5. CKD Secondary to Diabetic or Non Diabetic condition will also be included. 6. CKD secondary to Hypertension will also be included. 7. Subjects diagnosed of chronic glomerulonephritis will also be included. 8. Known cases of CKD and already on standard renal supportive medications for minimum 3 months will also be included 9. Subjects having serum creatinine less than 5mg by dl 10. Adult population of age 18 to 70 years. 11. uACR greater than or equal to 30mg/g.

Exclusion criteria

Exclusion criteria: 1. CKD stage 4 and 5 and ESRD Subjects will be excluded. 2. Subjects with Serum Creatinine greater than 5 mg by dl. 3. GFR less than 30 ml by min by 1.73m2 4. Hb less than 8 mg by dl. 5. Pregnancy and Puerperium will be excluded. 6. Paediatric age group below 18 years. 7. Subjects with HIV positive will be excluded. 8. Subjects on long use of steroids and immunosuppressive medications will be excluded. 9. Serum potassium greater than 5.5 mEq by L will be excluded.

Design outcomes

Primary

Measure	Time frame
Decrease in Serum creatinine ,Blood urea , eGFR values.Timepoint: 0th day and 91st day	—

Secondary

Measure	Time frame
improvements in subjective parameters 1. Dourbalya tiredness 2. Swasakrchratha breathlessness 3. Agnimandya Loss of appetite 4. Padasopha oedema of leg 5. Pandu pallor 6. Arohana ayasa- exertional dyspnoea 7. Mutrakshaya Oliguria 8. Aruchi-anorexia. Timepoint: 0th day and 91st day	—

Countries

India

Contacts

Public ContactDr Keerthi B S

Government Ayurveda Medical College and Hospital Mysore ( Affiliated to RGUHS University )

mythreyrc@gmail.com9513199733

Outcome results